Rimonabant

• Background:

  Rimonabant is a selective CB1 receptor inverse agonist (Ki = 1.8 nM) .1,2 It is an anorectic antiobesity drug originally approved for use in Europe but eventually withdrawn from the market because of potential severe psychiatric side effects.

• Conjugation:

  Unconjugated

• Buffer:

  White solid

• Storage Conditions:

  RT